共 28 条
- [21] Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registryLEUKEMIA & LYMPHOMA, 2018, 59 (01) : 85 - 96Hazar, VolkanKesik, VuralKarasuc, Gulsun TezcanOzturk, GulyuzKupesiz, AlphanKilic, Suar CakiAtas, ErmanUygun, VedatEker, NursahErbey, FatihBengoa, Sebnem YilmazEmir, SunaAnak, SemaOniz, HaldunDaloglu, HayriyeAksoylar, SerapKocak, UlkerKarakukcu, MusaElli, MuratKurucu, NilgunYesilipek, Akif c
- [22] Clinical trials update from the American Heart Association meeting:: Ω-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITEEUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (01) : 109 - 115Cleland, JGEFreemantle, NKaye, GNasir, MVelavan, PLalukota, KMudawi, TShelton, RClark, ALColetta, AP
- [23] Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trialSupportive Care in Cancer, 2021, 29 : 1629 - 1633Hirotaka MiyashitaChristina CruzCardinale Smith
- [24] Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trialSUPPORTIVE CARE IN CANCER, 2021, 29 (03) : 1629 - 1633Miyashita, HirotakaCruz, ChristinaSmith, Cardinale
- [25] Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) TrialBLOOD, 2014, 124 (21)Alvarnas, J.Le Rademacher, J.Wang, Y.Little, Richard F.Akpek, G.Ayala, E.Devine, S.Kaplan, L.Noy, A.Popat, U.Thompson, J.Horowitz, M. H.Mendizabal, A.Navarro, W. H.Ambinder, R.
- [26] Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients With Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) TrialCLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (02) : 13 - 14不详
- [27] Tandem Autologous Stem Cell Transplants (auto-auto) With or without Maintenance Therapy Versus Single Autologous Transplant Followed by HLA-Matched Sibling Non- Myeloablative Allogeneic Stem Cell Transplant (auto-allo) for Patients (pts) with High Risk (HR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0102 TrialBLOOD, 2010, 116 (21) : 233 - 234Stadtmauer, Edward A.Krishnan, AmritaPasquini, Marcelo C.Ewell, MarianAlyea, Edwin P., IIIAntin, Joseph H.Castro-Malaspina, HugoKassim, Adetola A.Negrin, RobertQazilbash, Muzaffar H.Rizzo, J. DouglasRowley, Scott D.Sahebi, FiroozehSomlo, GeorgeVesole, David H.Vogl, Dan T.Weisdorf, Daniel J.Geller, NancyHorowitz, Mary M.Maloney, David G.Giralt, Sergio
- [28] Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) with or without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non- Myeloablative Allogeneic HCT (auto-allo) for Patients with Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 TrialBLOOD, 2010, 116 (21) : 24 - 25Krishnan, AmritaPasquini, Marcelo C.Ewell, MarianStadtmauer, Edward A.Alyea, Edwin P., IIIAntin, Joseph H.Comenzo, Raymond L.Goodman, StaceyHari, ParameswaranNegrin, RobertQazilbash, Muzaffar H.Rowley, Scott D.Sahebi, FiroozehSomlo, GeorgeVesole, David H.Vogl, Dan T.Weisdorf, Daniel J.Geller, NancyHorowitz, Mary M.Giralt, SergioMaloney, David G.